The Customs, Excise & Service Tax Appellate Tribunal set aside a massive differential duty demand on the ground that the appellant had correctly classified Nicotine Sulphate under Chapter 29, that the revenue’s extended-period claim was barred by limitation, and that no related-party liability existed.
Background & Facts
The Dispute
M/s BGP International (appellant), a manufacturer of organic manure and Nicotine Sulphate in Mehsana, Gujarat, was assessed by the Commissioner of Central Excise for mis-classification of Nicotine Sulphate. The department argued that the product fell under CTH 24039990 (Chapter 24 - Tobacco substitutes) instead of the appellant’s declared CTH 29399900 (Chapter 29 - Alkaloids and derivatives). The assessment also included a claim of undervaluation of sales to M/s BGP Healthcare Pvt. Ltd. (BHPL) and invoked the extended period under Section 11A of the Central Excise Act, 1944.
Key Facts
- 08.03.2016: Sample of Nicotine Sulphate drawn from BHPL premises (third-party site).
- 20.06.2017: First CRCL test report (Vadodara) concluded the product was a tobacco extract, classifying it under CTH 24039990.
- 16.02.2018: Samples drawn from appellant’s own factory.
- 02.04.2018: Second CRCL report (Vadodara) identified the material as an aqueous solution of Nicotine Sulphate.
- 21.01.2019: Re-testing of 2018 sample sent to CRCL, New Delhi.
- 20.05.2019: Third CRCL report (New Delhi) confirmed composition as 47.4% Nicotine Sulphate and 36.4% Nicotine.
- 07.04.2006: Letter from M/s Alchem International (now BGP International) to the Deputy Commissioner informing about manufacture of Nicotine Sulphate under HS Code 29397002.
- 16.06.2020: Show-cause notice invoking extended period for the period June-2015 to June-2017, demanding differential duty of Rs.4,60,00,920.
- 17.06.2020: Additional show-cause notice demanding differential duty of Rs.3,56,475 for alleged undervaluation of sales to BHPL.
- 05.10.2020: Commissioner’s impugned order upheld the re-classification and confirmed duty, interest (Section 11AA) and penalty (Section 11AC).
- April-2015: ER-1 return filed by appellant showing clearance of Nicotine Sulphate under CTH 29399900.
- 22.06.2026: Hearing before the West Zonal Bench, Ahmedabad.
- 29.07.2026: Tribunal’s final order.
Procedural History
- 12.06.2019: Original assessment order issued (not detailed in judgment).
- 05.10.2020: Commissioner’s order confirming re-classification and differential duty.
- 22.06.2026: Appeal filed before CESTAT West Zonal Bench (Excise Appeal No. 10003 of 2021-DB).
- 29.07.2026: Tribunal delivered its judgment, allowing the appeal.
Parties' Positions
- Appellant: Asserted that Nicotine Sulphate is a vegetable alkaloid salt, properly placed under CTH 2939; argued that the department ignored the 2006 letter, the ER-1 returns, and the later CRCL reports; contended that the sampling procedure violated the CBIC Supplementary Manual and BIS standards; denied any related-party relationship with BHPL under Section 4(3)(b) of the Central Excise Act.
- Respondent (Commissioner): Relied on the 2017 CRCL report, the chemical examiner’s opinion, and the alleged related-party link (common director) to justify re-classification, undervaluation, and the invocation of the extended period.
Relief Sought
The appellant sought a setting aside of the differential duty of Rs.4,60,00,920, the additional Rs.3,56,475 undervaluation demand, and the associated interest and penalty, along with costs.
The Legal Issue
The central questions were: (a) Whether the revenue’s claim for central excise duty is barred by the limitation period despite invoking the extended period under Section 11A; (b) Whether Nicotine Sulphate should be classified under CTH 2939 (Chapter 29) or CTH 2403 (Chapter 24) pursuant to the HSN explanatory notes and Note 1(a) of Chapter 29; and (c) Whether M/s BGP International and M/s BGP Healthcare Pvt. Ltd. qualify as related parties under Section 4(3)(b) of the Central Excise Act, 1944.
Arguments Presented
For the Appellant
- Submitted the 2006 letter and ER-1 returns as evidence of prior disclosure, negating any allegation of suppression.
- Cited Camlin Ltd. v. Commissioner of Customs and Mclloyds & Company v. Commissioner of Customs to argue that the chemical examiner’s opinion is not determinative for classification.
- Relied on Collector of Central Excise, Hyderabad v. Bakelite Hylam Ltd. to emphasize the primacy of HSN explanatory notes in tariff interpretation.
- Asserted that the sampling from BHPL violated the CBIC Supplementary Manual (presence of owner/manager required) and that the 2017 test report breached IS:10627:1983 by being issued more than a year after sample collection.
- Contended that the common director does not satisfy the “mutuality of business interest” test laid down in UOI v. Atic Industries.
For the Respondent
- Maintained that the 2017 CRCL report, coupled with the chemical examiner’s remark, conclusively placed the product under CTH 24039990.
- Argued that the appellant’s omission of the Nicotine Sulphate content in the returns amounted to suppression, justifying the extended period.
- Relied on the presence of a common director to establish a related-party relationship, invoking Section 4(3)(b) and the valuation rule of 110% of cost of production.
- Cited Usha Rectifier Corp. (I) Ltd. v. CCE and Mahavir Plastics v. CCE to support the revenue’s stance on related-party valuation.
The Court's Analysis
The Tribunal first examined the limitation issue. It observed that the show-cause notice dated 16.06.2020 sought recovery for the period June-2015 to June-2017, well beyond the three-year limitation prescribed under the Central Excise Act. The revenue had invoked the extended period under Section 11A, but the Tribunal held that the extension could not be invoked where the department itself had been duly informed of the correct classification through the 2006 letter and the regular ER-1 returns. Citing Apex Electricals Pvt. Ltd. v. UOI and Cadila Pharmaceutical Ltd. v. CCE, the Tribunal emphasized that non-submission of information not required by law does not amount to suppression.
"From the above evidence, it is clear that classification of Nicotine Sulphate by appellant under Chapter Heading 2939 was already intimated to the department and therefore, there is no ground to allege suppression, misstatement etc. in the case to invoke extended period."
On classification, the Tribunal noted that Note 1(a) of Chapter 29 restricts the chapter to “separate chemically defined compounds”. However, the Tribunal relied on the Supreme Court’s pronouncement in Collector of Central Excise, Hyderabad v. Bakelite Hylam Ltd. that the HSN explanatory notes are the authoritative guide for interpreting tariff headings. The explanatory notes for Chapter 29 expressly include “alkaloids and their derivatives” (heading 29.39). The Tribunal found that Nicotine Sulphate, being a sulphate salt of the alkaloid nicotine, fits squarely within this definition. Moreover, the Tribunal accepted the later CRCL reports (2018, 2019) which identified the material as an organic chemical rather than a tobacco extract, and rejected the 2017 report on the basis of procedural non-compliance with BIS standards and the sampling manual.
Regarding the related-party claim, the Tribunal examined Section 4(3)(b) of the Central Excise Act, which requires a “mutuality of business interest” and a “common control” beyond mere common directorship. Referring to UOI v. Atic Industries and UOI v. Hind Lamps, the Tribunal held that the presence of a single common director does not satisfy the statutory test. Consequently, the alleged related-party transaction could not be the basis for a differential duty demand.
Finally, the Tribunal addressed the revenue’s reliance on the chemical examiner’s opinion. It reiterated the principle from Camlin Ltd. that the chief chemist’s role is limited to analytical data, not classification. Hence, the examiner’s classification opinion was deemed irrelevant.
The Verdict
The appeal is allowed. The Tribunal sets aside the differential duty of Rs.4,60,00,920, the additional Rs.3,56,475 undervaluation demand, and the interest and penalty under Sections 11AA and 11AC of the Central Excise Act, 1944. No monetary award is granted to either party, and costs are awarded to the appellant. The demand for duty for the period June-2015 to June-2017 is held barred by limitation.
What This Means For Similar Cases
Limitation Bars Extended-Period Claims
- Practitioners must ensure that any claim for duty beyond the standard limitation is supported by a clear statutory basis and that the department has not already been informed of the correct classification.
- A prior disclosure (e.g., letters, returns) defeats the revenue’s argument of suppression and precludes invoking the extended period.
HSN Explanatory Notes Govern Tariff Classification
- Courts will treat the HSN explanatory notes as the definitive interpretative aid for tariff headings.
- Products that are chemically defined salts of alkaloids fall within Chapter 29 even if they contain minor impurities.
- Reliance on outdated or procedurally flawed test reports will be rejected.
Related-Party Definition Requires Substantive Mutual Interest
- Merely sharing a director or partner does not satisfy Section 4(3)(b); there must be demonstrable mutuality of business interest or control.
- Valuation under Rule 9 of the Central Excise Valuation Rules applies only when a genuine related-party relationship is established.
Practical Takeaways
- Verify that sampling complies with the CBIC Supplementary Manual and BIS standards; otherwise, test reports may be excluded.
- Preserve all correspondence (letters, returns) that disclose product classification to pre-empt suppression allegations.
- When alleging related-party transactions, be prepared to produce documentary evidence of mutual control beyond common directors.
